Costa Rica vs Ecuador: New cases tested for RR-/MDR-TB
Costa Rica
100.0%
in 2024
Ecuador
100.0%
in 2024
Costa Rica rank
1st
Ecuador rank
1st
New cases tested for RR-/MDR-TB over time
- Costa Rica
- Ecuador
How they compare
Costa Rica currently reports 100.0% against 100.0% in Ecuador, a difference of 0.0%.
The two have swapped places 8 times across 13 shared years of data; in 2005 it was Ecuador ahead.
Costa Rica ranks 1st and Ecuador ranks 1st of 192 countries.
Across the 3 decades both report, Costa Rica averaged higher in 1 and Ecuador in 2.
Head to head by decade
| Decade | Costa Rica | Ecuador | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 0.2% | 3.2% | 2.9% | Ecuador |
| 2010s | 53.1% | 21.1% | 32.0% | Costa Rica |
| 2020s | 70.8% | 99.2% | 28.5% | Ecuador |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher new cases tested for rr-/mdr-tb, Costa Rica or Ecuador?
- Costa Rica, at 100.0% against 100.0% in Ecuador as of 2024.
- What is the difference in new cases tested for rr-/mdr-tb between Costa Rica and Ecuador?
- 0.0%, with Costa Rica ahead.
- How many years of comparable data are there for Costa Rica and Ecuador?
- 13 years are reported by both, from 2005 to 2024.
- How do Costa Rica and Ecuador rank globally for new cases tested for rr-/mdr-tb?
- Costa Rica ranks 1st and Ecuador ranks 1st of 192 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as New cases tested for RR-/MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.